Definition of Pralsetinib. Meaning of Pralsetinib. Synonyms of Pralsetinib

Here you will find one or more explanations in English for the word Pralsetinib. Also in the bottom left of the page several parts of wikipedia pages related to the word Pralsetinib and, of course, Pralsetinib synonyms and on the right images related to the word Pralsetinib.

Definition of Pralsetinib

No result for Pralsetinib. Showing similar results...

Meaning of Pralsetinib from wikipedia

- Pralsetinib, sold under the brand name Gavreto, is a medication approved for RET mutation-positive medullary thyroid cancer (MTC) and RET fusion-positive...
- include Pembrolizumab, Larotrectinib, Selpercatinib, Entrectinib, and Pralsetinib. Pembrolizumab was approved by the US Food and Drug Administration in...
- 2017, the first selective RET inhibitors selpercatinib (LOXO-292) and pralsetinib (BLU-667) started their first phase I/II clinical trials in solid tumors...
- myeloma Satralizumab Genentech neuromyelitis optica spectrum disorder Pralsetinib Blueprint Medicines Corp RET fusion-positive non-small cell lung cancer...
- Masitinib Midostaurin Nintedanib Odronextamab Pazopanib Pexidartinib Pralsetinib Quizartinib Regorafenib Repotrectinib Ripretinib Selpercatinib Sitravatinib...
- Avapritinib L01EX19 Ripretinib L01EX21 Tepotinib L01EX22 Selpercatinib L01EX23 Pralsetinib L01EX24 Surufatinib L01EX25 Umbralisib L01EX26 Sitravatinib L01EX27 Capivasertib...
- malignancies, newer selective inhibitors (such as selpercatinib and pralsetinib) have shown significant activity in both mutations and fusions. The results...
- Masitinib Midostaurin Nintedanib Odronextamab Pazopanib Pexidartinib Pralsetinib Quizartinib Regorafenib Repotrectinib Ripretinib Selpercatinib Sitravatinib...
- is in development as a potential treatment for leukemia. Enbezotinib Pralsetinib Resigratinib Selpercatinib Zeteletinib Butler MS (September 2013). "Remediating...
- inhibitor (FGFRi) and is in early stage human clinical trials. Enbezotinib Pralsetinib Rebecsinib Selpercatinib Zeteletinib Franovic A, Mohan A, Uryu S, Wu...